AI assistant
Spineway — Audit Report / Information 2018
Jan 11, 2019
1683_iss_2019-01-11_7ae5db65-6962-4b2e-8bd7-f0e90941f3c8.pdf
Audit Report / Information
Open in viewerOpens in your device viewer
LIQUIDITY CONTRACT ANNUAL REPORT
Regarding liquidity contract granted by SPINEWAY to PORTZAMPARC, the liquidity account held the following assets on December 31st 2018:
- § 87,655 shares SPINEWAY,
- § 6,247.50 €.
At June 30th 2018 report, the position of this liquidity contract was:
- § 37,149 shares SPINEWAY,
- § 13,599.91 €.
Next communication: 2018 full year sales – January 16, 2019 after market closing
SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLAN FOR SMES) Find out all about Spineway at www.spineway.com
This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column. Spineway has an international network of over 50 independent distributors and 90% of its turnover comes from exports. Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), received the OSEO Excellence award as well as the Deloitte Fast 50 award in 2011. Rhône Alpes INPI Patent Innovation Award (2013) – Talent INPI award (2015). ISIN code: FR0011398874 - ALSPW
Investor Relations David Siegrist – Finance Director Tel: +33 (0)4 72 77 01 52 [email protected]
Financial Communication Jérôme Gacoin / Solène Kennis Tel: +33 (0)1 75 77 54 68 [email protected]